FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Apr 27, 2017
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on April 27, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 3cdb9466-f919-4fde-b8dd-cd2b15dc5e86
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1014325
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Biomat USA Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 25, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 9, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 10, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 28, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc
- FDA Inspection 1249375 - 2024-08-14
- FDA Inspection 1096834 - 2019-06-25
- FDA Inspection 921477 - 2015-04-09
- FDA Inspection 831630 - 2013-04-10
- FDA Inspection 722294 - 2011-04-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.